Skip to main content
Premium Trial:

Request an Annual Quote

Mitch Eggers,Robert Ellis, David Jorden, Deval Lashkari


On June 24, a day before Genometrix closed its doors, founder and chief executive officer Mitch Eggers resigned from the Woodlands, TX-based microarray services and gene expression software company to start a new genomics company.

Eggers said initial venture capital financing for the company will be completed within 60 to 90 days. The company will involve former employees of Genometrix, which ran out of cash in late June after canceling its initial public offering in March.

"The idea is to take things learned through Genometrix and some of the employees and put together a second venture funded through venture capital," said Eggers. "We learned in the first company that we have to have something up front. It would have been good for us as we went into the IPO phase."

The new company, Eggers said, is likely to be located either in Austin, TX, or in San Diego for financing reasons.


Robert Ellis, Genometrix''s president, has also resigned from the company to seek a new position, while David Jorden, the firm''s CFO, and Deval Lashkari, vice president of business development and marketing, have stayed on along with three other employees to either oversee the dissolution of Genometrix or to restart the company. Thirty-five other employees were laid off June 25.

"We''ll know within two weeks whether we have a realistic option of restarting the company," Jorden told GenomeWeb earlier. "If we end up on the path to liquidation, in five to eight weeks it will be consummated."

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.